#NIH clinical trial of investigational vaccine for #COVID_19 begins
Friday, 27 March, 2020, 11:25
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the trial. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccine today.
The study is evaluating different doses of the experimental vaccine for safety and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
SpaceX's Dragon: First Private Spacecraft to Reach the Space Station (video)64031.05.2020, 20:50
Baby girl has second mouth complete with lips (photo)98829.05.2020, 16:00
Experts warn сclimate сhange is already killing way more people than we record54529.05.2020, 05:35
What's New in #iOS1370028.05.2020, 17:40